Position in LLY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$10,847,645
+$2,591,791 QoQ
Shares Held
9,044
+0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.78%
of 13F equity value
Holder Rank
#1,217
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Montecito Bank & Trust holds $27,844,791 across 8 Drug Manufacturers - General names. LLY ranks #1 (39.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
9,044 | $10,847,645 | |
| 2 | ABBV |
AbbVie Inc.
|
29,468 | $7,415,326 | |
| 3 | JNJ |
Johnson & Johnson
|
17,089 | $4,340,092 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,223 | $2,727,155 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
6,872 | $868,208 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,596 | $725,780 | |
| 7 | PFE |
Pfizer Inc
|
26,984 | $649,773 | |
| 8 | NVS |
Novartis AG
|
1,728 | $270,812 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,847,645 | 9,044 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $8,255,854 | 8,976 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $9,925,745 | 9,236 | Shares | Defined | 2026-01-09 | |
| 2025-09-30 | $7,485,030 | 9,810 | Shares | Defined | 2025-10-07 | |
| 2025-03-31 | $8,594,418 | 10,406 | Shares | Defined | 2025-04-17 | |
| 2024-12-31 | $7,946,196 | 10,293 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $9,507,021 | 10,731 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $9,022,110 | 9,965 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $7,846,503 | 10,086 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $6,061,784 | 10,399 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $5,636,104 | 10,493 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $4,835,182 | 10,310 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $3,718,895 | 10,829 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $4,118,626 | 11,258 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $3,751,182 | 11,601 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $3,826,885 | 11,803 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $3,420,116 | 11,943 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $3,311,325 | 11,988 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $2,778,145 | 12,024 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,737,714 | 11,928 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $2,395,032 | 12,820 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,825,835 | 10,814 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $1,530,970 | 10,343 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,725,695 | 10,511 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,049,416 | 7,565 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||